Antimicrobial Agents Practice Questions

Q: What is the longest-acting cephalosporin?

Ceftriaxone. **Explanation:** **Ceftriaxone** is a third-generation parenteral cephalosporin distinguished by its exceptionally long elimination half-life (approximately **8 hours**). This is significantly longer than most other cephalosporins, which typically have half-lives of 1–2 hours. The prolonged duration of action is due to its high degree of plasma protein binding (approx. 90–95%) and its unique dual route of excretion (40% biliary, 60% renal). This pharmacokinetic profile allows for convenient **once-daily dosing**, making it a preferred choice for outpatient parenteral antibiotic therapy (OPAT). **Analysis of Incorrect Options:** * **Ceftazidime:** A third-generation cephalosporin with a half-life of ~1.5–2 hours. It is primarily used for its potent activity against *Pseudomonas aeruginosa*. * **Cefoperazone:** Another third-generation agent with a half-life of ~2 hours. While it is primarily excreted via bile, it requires twice-daily dosing. * **Cefotaxime:** A third-generation agent with a short half-life (~1 hour) due to rapid metabolism into an active metabolite (desacetylcefotaxime). It usually requires dosing every 6–8 hours. **High-Yield Clinical Pearls for NEET-PG:** * **Biliary Sludging:** Ceftriaxone can precipitate with calcium in the gallbladder, leading to "pseudolithiasis." * **Neonatal Contraindication:** It is avoided in neonates (especially prematures) because it displaces bilirubin from albumin, increasing the risk of **kernicterus**. * **No Renal Adjustment:** Due to its significant biliary excretion, dosage adjustment is generally not required in patients with isolated renal failure. * **DOC:** Ceftriaxone is the drug of choice for **Gonorrhea, Enteric Fever (Typhoid), and Bacterial Meningitis.**

Q: All of the following are anti-Pseudomonal drugs except?

Cefadroxil. **Explanation:** The correct answer is **Cefadroxil**. This question tests the classification and spectrum of activity of Cephalosporins and Penicillins, specifically regarding their efficacy against *Pseudomonas aeruginosa*. **1. Why Cefadroxil is the correct answer:** Cefadroxil is a **First-generation Cephalosporin**. First-generation agents (like Cefazolin and Cephalexin) have a narrow spectrum, primarily targeting Gram-positive cocci and a few Gram-negative organisms (PEcK: *Proteus, E. coli, Klebsiella*). They lack the structural stability to resist the beta-lactamases produced by *Pseudomonas*, making them ineffective against this pathogen. **2. Why the other options are incorrect:** * **Piperacillin (Option A):** An **Antipseudomonal Penicillin** (Ureidopenicillin). It is specifically designed with an extended side chain to penetrate the outer membrane of *Pseudomonas*. It is often combined with Tazobactam. * **Cefoperazone (Option B):** A **Third-generation Cephalosporin** with specific antipseudomonal activity. Notably, it is primarily excreted via bile, making it useful in patients with renal failure. * **Ceftazidime (Option C):** Another **Third-generation Cephalosporin** and historically the "gold standard" for *Pseudomonas* among cephalosporins. **Clinical Pearls for NEET-PG:** * **Antipseudomonal Cephalosporins:** Ceftazidime (3rd gen), Cefoperazone (3rd gen), and Cefepime (4th gen). Note: **Ceftriaxone** (3rd gen) does NOT cover *Pseudomonas*. * **Antipseudomonal Carbapenems:** Imipenem, Meropenem, and Doripenem. **Ertapenem** is the exception (no *Pseudomonas* coverage). * **Other agents:** Aminoglycosides (Amikacin/Tobramycin), Fluoroquinolones (Ciprofloxacin/Levofloxacin), and Monobactams (Aztreonam). * **Mnemonic for 1st Gen Cephalosporins:** "If it has **'pha'** or **'fa'** and ends in **'in'** or **'il'**, it’s 1st gen" (e.g., Ce**pha**lex**in**, Ce**fa**drox**il**).

Q: What is the mechanism of action of Fluconazole?

Inhibits lanosterol 14 demethylase. **Mechanism of Action: Fluconazole** **Correct Answer: B. Inhibits lanosterol 14-α-demethylase** Fluconazole is an **Azole** antifungal. Its primary mechanism involves the inhibition of the fungal cytochrome P450 enzyme, **14-α-demethylase**. This enzyme is responsible for converting lanosterol into **ergosterol**, a vital component of the fungal cell membrane. The depletion of ergosterol and the accumulation of methylated sterols lead to increased membrane permeability and fungal cell death. **Explanation of Incorrect Options:** * **A. Inhibits fungal mitosis:** This is the mechanism of **Griseofulvin**, which binds to tubulin and disrupts the mitotic spindle. * **C. Inhibits squalene epoxidase:** This is the mechanism of **Allylamines** (e.g., Terbinafine). It prevents the conversion of squalene to lanosterol, leading to toxic squalene accumulation. * **D. Inhibits β-1,3-glucan synthase:** This is the mechanism of **Echinocandins** (e.g., Caspofungin, Micafungin), which disrupt the synthesis of the fungal cell wall rather than the cell membrane. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Fluconazole is the drug of choice for *Candida albicans* and Cryptococcal meningitis (maintenance therapy). * **Resistance:** *Candida krusei* is inherently resistant to fluconazole; *Candida glabrata* shows dose-dependent resistance. * **Pharmacokinetics:** It has excellent CSF penetration and is the only azole primarily excreted unchanged in the urine (useful for fungal UTIs). * **Side Effects:** It is a potent inhibitor of CYP enzymes (though less than Ketoconazole), leading to significant drug-drug interactions (e.g., with Warfarin, Phenytoin).

Q: What is the treatment for isoniazid-induced neuropathy?

Pyridoxine. **Explanation:** **Mechanism of Action (Why Pyridoxine is correct):** Isoniazid (INH) is a structural analog of **Pyridoxine (Vitamin B6)**. It induces peripheral neuropathy through two primary mechanisms: 1. It inhibits the enzyme **pyridoxine phosphokinase**, which is essential for converting pyridoxine into its active form, pyridoxal-5-phosphate (PLP). 2. It reacts with pyridoxine to form **isonicotinyl-hydrazones**, which are rapidly excreted in the urine. This depletion of Vitamin B6 impairs the synthesis of neurotransmitters like GABA, leading to symmetrical peripheral neuropathy (paresthesia, numbness). Administering supplemental Pyridoxine bypasses this deficiency and prevents/treats the nerve damage. **Analysis of Incorrect Options:** * **A. Thiamine (B1):** Deficiency causes Beriberi and Wernicke-Korsakoff syndrome, typically associated with chronic alcoholism, not INH therapy. * **C. Niacin (B3):** While INH can theoretically cause Pellagra (by inhibiting the conversion of tryptophan to niacin), it is not the primary cause of the characteristic peripheral neuropathy. * **D. Riboflavin (B2):** Deficiency leads to cheilosis, glossitis, and corneal vascularization, but it has no role in INH-induced neurotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 10–25 mg/day of Pyridoxine is given to high-risk patients (diabetics, alcoholics, pregnant women, malnourished) starting INH. * **Therapeutic Dose:** If neuropathy develops, the dose is increased to 50–100 mg/day. * **Metabolism:** INH is metabolized by **Acetylation** (Phase II reaction). **Slow acetylators** are at a significantly higher risk of developing peripheral neuropathy. * **Sideroblastic Anemia:** INH can also cause microcytic anemia because Vitamin B6 is a cofactor for ALA synthase in heme synthesis.

Q: What is the strength of topical ophthalmic preparations of tobramycin?

3 mg/ml. **Explanation:** **Tobramycin** is a potent, broad-spectrum aminoglycoside antibiotic primarily used for treating external ocular infections caused by susceptible bacteria, particularly *Pseudomonas aeruginosa*. **1. Why 3 mg/ml is correct:** The standard concentration for topical ophthalmic tobramycin solution (eye drops) is **0.3%**. In pharmaceutical calculations, a 1% solution equals 10 mg/ml. Therefore, a 0.3% solution corresponds to **3 mg/ml**. This concentration is clinically optimized to provide maximum bactericidal efficacy against common ocular pathogens while remaining non-toxic to the corneal epithelium. **2. Analysis of incorrect options:** * **8 mg/ml (Option B):** This is an arbitrary value and does not correspond to standard ophthalmic formulations. * **10 mg/ml (Option C):** This represents a 1% concentration. While some antibiotics (like Chloramphenicol) are used at 1%, Tobramycin at this strength would increase the risk of local irritation and ocular surface toxicity. * **13 mg/ml (Option D):** This is incorrect. However, it is important to note that "fortified" aminoglycoside drops (used for severe bacterial keratitis) are prepared by pharmacists at much higher concentrations (e.g., 14 mg/ml), but these are not standard commercial preparations. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Tobramycin has superior activity against *Pseudomonas* compared to Gentamicin. * **Formulations:** It is available as a 0.3% solution (drops) and a 0.3% ointment. * **TobraDex:** A common clinical combination containing Tobramycin (0.3%) and Dexamethasone (0.1%). * **Side Effect:** Prolonged topical use may lead to localized ocular toxicity, including punctate keratitis and lid itching/swelling. * **Mechanism:** Like all aminoglycosides, it inhibits bacterial protein synthesis by binding to the **30S ribosomal subunit**.

Q: All penicillins act by:

Inhibiting cell wall synthesis. ### Explanation **Correct Option: B. Inhibiting cell wall synthesis** Penicillins belong to the **Beta-lactam** class of antibiotics. Their primary mechanism of action involves inhibiting the synthesis of the bacterial cell wall. 1. **Binding:** Penicillins bind to specific receptors on the bacterial cytoplasmic membrane called **Penicillin-Binding Proteins (PBPs)** (e.g., transpeptidases). 2. **Inhibition:** They inhibit the **transpeptidation reaction**, which is the final step in peptidoglycan synthesis. This prevents the cross-linking of glycan chains. 3. **Lysis:** The loss of structural integrity, combined with the activation of bacterial autolytic enzymes (murein hydrolases), leads to osmotic rupture and bacterial death (**Bactericidal** action). **Why other options are incorrect:** * **A. Inhibiting protein synthesis:** This is the mechanism for drugs like Aminoglycosides, Tetracyclines, Macrolides, and Chloramphenicol (acting on 30S or 50S ribosomal subunits). * **C. Antifolate:** This describes the mechanism of Sulfonamides (inhibits dihydropteroate synthase) and Trimethoprim (inhibits dihydrofolate reductase). * **D. Inhibits DNA gyrase:** This is the mechanism of **Fluoroquinolones** (e.g., Ciprofloxacin), which inhibit Topoisomerase II (DNA gyrase) and IV. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** The most common mechanism of resistance to penicillins is the production of **Beta-lactamases** (penicillinases) that hydrolyze the beta-lactam ring. * **Spectrum:** Natural Penicillin (Pen G) is the drug of choice for **Syphilis** (*Treponema pallidum*). * **Adverse Effect:** The most serious side effect is **Type I Hypersensitivity** (Anaphylaxis). Always perform a Skin Hypersensitivity Test (SHT) before administration. * **Excretion:** Most penicillins are excreted renally via tubular secretion; **Probenecid** can be used to prolong their half-life by inhibiting this secretion.

Q: What is the preferred fluoroquinolone against Mycobacterium leprae?

Ofloxacin. **Explanation:** **Ofloxacin** is considered the preferred fluoroquinolone for the treatment of leprosy. While several fluoroquinolones exhibit bactericidal activity against *Mycobacterium leprae* by inhibiting DNA gyrase, Ofloxacin has been the most extensively studied in clinical trials and is a recognized component of WHO-recommended alternative multidrug therapy (MDT) regimens for patients who cannot tolerate standard drugs like Rifampicin or Dapsone. **Analysis of Options:** * **Ofloxacin (A):** It is highly effective against *M. leprae*. In clinical practice, a dose of 400 mg daily is used. It is the standard fluoroquinolone included in the ROM (Rifampicin, Ofloxacin, Minocycline) regimen for single-lesion paucibacillary leprosy. * **Pefloxacin (B):** While Pefloxacin also shows significant activity against *M. leprae*, it is less commonly used than Ofloxacin due to a higher side-effect profile and less clinical documentation in standard leprosy protocols. * **Ciprofloxacin (C):** Although a potent antibacterial, Ciprofloxacin has relatively low bactericidal activity against *M. leprae* compared to Ofloxacin and is generally not used in leprosy management. * **Moxifloxacin (D):** Moxifloxacin is actually more potent than Ofloxacin *in vitro* and in animal models. However, Ofloxacin remains the "preferred" answer in the context of standard NEET-PG curriculum and established WHO guidelines for alternative MDT. **High-Yield Clinical Pearls for NEET-PG:** * **ROM Regimen:** A single dose of Rifampicin (600 mg), Ofloxacin (400 mg), and Minocycline (100 mg) was previously used for Single Lesion Paucibacillary (SLPB) leprosy. * **Mechanism:** Fluoroquinolones inhibit **DNA Gyrase (Topoisomerase II)**, preventing DNA replication. * **Alternative MDT:** For Rifampicin-resistant leprosy or cases of intolerance, a combination of Ofloxacin, Minocycline, and Clofazimine is often utilized.

Question 1

What is the treatment of choice for bacterial vaginosis?

Accepted Answer

Metronidazole

Answer

Clindamycin

Answer

Erythromycin

Answer

Ampicillin

Question 2

What is the longest-acting cephalosporin?

Accepted Answer

Ceftriaxone

Answer

Ceftazidime

Answer

Cefoperazone

Answer

Cefotaxime

Question 3

What is the recommended treatment regimen for Brucella infection according to WHO guidelines?

Accepted Answer

Rifampicin with doxycycline

Answer

Streptomycin with doxycycline

Answer

Rifampicin with ciprofloxacin

Answer

Streptomycin with erythromycin

Question 4

All of the following are anti-Pseudomonal drugs except?

Accepted Answer

Cefadroxil

Answer

Piperacillin

Answer

Cefoperazone

Answer

Ceftazidime

Question 5

What is the mechanism of action of Fluconazole?

Accepted Answer

Inhibits lanosterol 14 demethylase

Answer

Inhibits fungal mitosis

Answer

Inhibits squalene epoxidase

Answer

Inhibit ß1,3 glucan synthase

Question 6

What is the treatment for isoniazid-induced neuropathy?

Accepted Answer

Pyridoxine

Answer

Thiamine

Answer

Niacin

Answer

Riboflavin

Question 7

What is the strength of topical ophthalmic preparations of tobramycin?

Accepted Answer

3 mg/ml

Answer

8 mg/ml

Answer

10 mg/ml

Answer

13 mg/ml

Question 8

All penicillins act by:

Accepted Answer

Inhibiting cell wall synthesis

Answer

Inhibiting protein synthesis

Answer

Antifolate

Answer

Inhibits DNA gyrase

Question 9

What is the preferred fluoroquinolone against Mycobacterium leprae?

Accepted Answer

Ofloxacin

Answer

Pefloxacin

Answer

Ciprofloxacin

Answer

Moxifloxacin

Question 10

Which of the following is NOT a third-generation cephalosporin?

Accepted Answer

Cefuroxime

Answer

Ceftriaxone

Answer

Cefotaxime

Answer

Ceftizoxime

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?